Depression care is rarely a one-appointment process, especially when prior medications have not delivered enough relief. The National Alliance on Mental Illness reports that about 60% of people beginning depression medication need to try more than one medication before their symptoms resolve. Treatment-resistant depression is often used to describe ongoing symptoms after two or more antidepressants have been tried adequately.
That is why a complete plan may include psychiatric evaluation, medication management, talk therapy, insurance approval, symptom monitoring, transportation, and caregiver support. Spravato is not an at-home treatment. The FDA explains that esketamine is administered in a certified healthcare setting, where patients are monitored for sedation and dissociation for at least two hours after each dose.
For example, a Utah County adult who has tried two antidepressants may need a clinician to assess eligibility, help understand benefits, a safe ride home, and ongoing therapy between appointments. Each organization below fills one part of that real-world care pathway. This is not a ranking of competitors.
How This Care Network Was Selected
This roundup was built around the practical questions patients and families ask: Who evaluates whether Spravato is appropriate? Who helps move medication and authorization forward? How does a patient get home safely after treatment? Where can loved ones find understandable information and crisis support? The included organizations were selected because they have a distinct, documented role in those steps.
Etherios Therapy is the central inclusion because it is the local clinical point of coordination. Its Orem location, free 15-minute consultation, in-person Spravato pathway, insurance review, and follow-up-oriented approach make it the provider that connects the other resources into an actionable Utah County plan. The remaining organizations are included for complementary medication, pharmacy, transportation, and education roles.
How To Choose A Spravato Treatment Provider
- Confirm that treatment is administered in person through the required safety program.
- Ask who performs the psychiatric eligibility evaluation and reviews prior treatment history.
- Ask whether the clinic assists with insurance verification and prior authorization.
- Confirm the observation period, side-effect response process, and discharge instructions.
- Ask how progress is measured and how the clinic coordinates with therapists or outside prescribers.
- Arrange transportation before the first visit, because patients should not drive after treatment.
- Request a clear explanation of office, medication, and insurance-related costs.
Common Mistakes To Avoid When Looking For Depression Care
- Choosing solely on an advertised price without confirming safety monitoring and follow-up.
- Assuming ketamine infusion therapy, compounded ketamine, and FDA-approved Spravato are identical services.
- Waiting to ask about insurance approval, transportation, or caregiver support until treatment day.
- Stopping an oral antidepressant or changing medication without prescriber guidance.
- Expecting one treatment modality to replace therapy, medical follow-up, or crisis support.
Etherios Therapy
Etherios Therapy is the local clinical anchor of this network, offering in-person Spravato care in Orem, Utah. For someone searching for a Spravato treatment center near me, Etherios Therapy provides a clear first step through consultation, psychiatric review, treatment planning, insurance support, monitored administration, and follow-up.
Its documented access features create a strong case for its leadership role in Utah County care coordination: the practice lists a free 15-minute consultation, requires regular in-person visits in Orem for Spravato therapy, and identifies 388 W Center St as its clinic address. Rather than presenting Spravato as a stand-alone service, Etherios Therapy can help patients plan the surrounding clinical and logistical steps.
Why It’s On The List
- Local in-person access: Spravato treatment is provided at the Orem clinic, creating a practical option for patients in Utah County.
- Structured start: A 15-minute consultation gives prospective patients a defined opportunity to discuss prior medication history and next steps.
- Insurance coordination: The intake pathway identifies major insurers, including UnitedHealthcare, Aetna, Select Health, Regence BlueCross BlueShield, EMI Health, UMR, DMBA, Medicare, Medicaid, and PEHP.
- Broader support: Medication management and therapy connections can help place monitored medication treatment within a more complete mental health plan.
Johnson & Johnson
Johnson & Johnson, through Janssen, is the manufacturer associated with Spravato. Its role in this ecosystem is medication development, prescribing information, REMS education, and research updates, not local patient treatment.
Why It’s On The List
- Medication source: Spravato is an esketamine nasal spray with FDA-approved uses for eligible adults.
- Recent regulatory context: In January 2025, the FDA approved Spravato as monotherapy for adults with treatment-resistant depression who had an inadequate response to at least two oral antidepressants.
- Research context: Johnson & Johnson reported March 2026 ECHO study findings describing treatment-effect durability for six months after discontinuation. Patients should recognize this as company-reported research and discuss its relevance with a qualified clinician.
CVS Specialty
CVS Specialty can be a pharmacy coordination resource when a patient’s plan requires specialty pharmacy involvement. Not every Etherios Therapy patient will use CVS Specialty, and dispensing arrangements depend on the insurance plan and healthcare setting.
Why It’s On The List
- Prior authorization support: Specialty pharmacies may help transmit required documentation to an insurer.
- One-on-one assistance: CVS Specialty describes CareTeam support for patients using complex medications.
- Useful preparation: Patients can gather their insurance card, medication history, diagnosis information, and prescriber details before asking how their plan handles Spravato.
Uber Health
Uber Health represents the transportation layer of the care network. Transportation is not a minor detail when a monitored medication session ends with a no-driving instruction. Uber Health reports that 6 million people in the United States miss medical appointments each year because of transportation issues.
Why It’s On The List
- Supports safe discharge planning: A prearranged ride can help a patient avoid driving after treatment.
- Healthcare-coordinated trips: Organizations can arrange rides through a dashboard or API.
- Accessible communication: Riders can receive trip details by text or phone call and do not necessarily need the Uber app.
National Alliance On Mental Illness
The National Alliance on Mental Illness, commonly known as NAMI, is an education and support resource rather than a Spravato provider. It can help patients and families prepare better questions about medication, therapy, brain stimulation, and treatment-resistant depression.
Why It’s On The List
- Plain-language education: NAMI explains that many people benefit from medication and psychotherapy together.
- Family involvement: Caregivers can use the materials to understand appointment planning and supportive communication.
- Crisis direction: People in emotional distress can use the 988 Lifeline for confidential crisis support by calling, texting, or chatting.
Current Treatment-Resistant Depression News To Watch
In 2026, the most useful developments to follow are evidence updates, labeling changes, and insurance policies, not social-media treatment claims. The March 28, 2026, ECHO study announcement from Johnson & Johnson added real-world data to the discussion of esketamine durability. That does not mean Spravato is appropriate for every patient, covered by every plan, or a substitute for individualized psychiatric assessment.
A safer approach is to review current prescribing requirements with a qualified provider, verify benefits directly with the insurer, and plan transportation before scheduling treatment. When local clinical coordination, medication access, practical transportation, and education work together, patients have a more realistic foundation for consistent care.
